What is MK Proteins Ltd (MKPL) share price return in the past 10 years?

Data is not available for this company

What is the share price of MK Proteins Ltd (MKPL)?

Company share prices are keep on changing according to the market conditions. The current trading price of MK Proteins Ltd (MKPL) on 12-Jun-2026 16:59:59 at 16:59 is 4.72.

What is the P/E ratio of MK Proteins?

The latest standalone P/E ratio of MK Proteins as of 12-Jun-2026 is 25.94.

What is the P/B ratio of MK Proteins Ltd (MKPL)?

The latest standalone P/B ratio of MK Proteins Ltd (MKPL) as of 12-Jun-2026 is 2.32.

What is the 52-week high and low of MK Proteins Ltd (MKPL)?

The 52-week high of MK Proteins Ltd (MKPL) is Rs. 9.75 and the 52-week low is Rs. 3.80.

MK Proteins Ltd (MKPL) Share Analysis – Brand Strength, Quality & Valuation Zone & DeciZen Rating

Name: MK Proteins Ltd (MKPL)
Brand: MK Proteins

MK Proteins Ltd (MKPL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543919 NSE: MKPL Edible Oil | Small Cap | MK Proteins Share Price

MK Proteins Ltd (MKPL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543919 NSE: MKPL Edible Oil | Small Cap | MK Proteins Share Price

Key Metrics

Valuation Multiples

Market Cap

₹177 Cr.

Current Price

₹4.7

52-Week Low / High

₹4 / 10

TTM EPS

₹0.2

TTM Sales

₹383 Cr.

Book Value per Share

₹2

P/E Ratio

25.94

Lower than its 5-year historical median

Industry PE

Price to Book (P/B)

2.32

Lower than its 5-year historical median

Price to Sales (P/S)

0.46

Lower than its 5-year historical median

EV/EBITDA

18.23

Lower than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

12.87%

Outperforms industry median

Return on Capital Employed (ROCE)

13.46%

Outperforms industry median

Return on Assets (ROA)

7.30%

Operating Profit Margin

4.7%

Net Profit Margin

3.14%

Gross Profit Margin

4.4%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

9.09%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-24.98%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-25.07%

Asset Quality

Promoter Holding

74.82%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹39 Cr.

Equity

₹37.5 Cr.

Face Value

₹1

All Time Low / High

₹3.80 / 33.33

MK Proteins stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is MK Proteins Ltd a good quality company?

MK Proteins Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does MK Proteins Ltd performance compare with that of its Peers?

Q.1 Revenue growth of MK Proteins Ltd vs industry peers?

MK Proteins Ltd revenue CAGR is 6.64%, compared to the industry median CAGR of 4.81%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of MK Proteins Ltd?

Promoters hold 74.82% of the MK Proteins Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of MK Proteins Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of -42.45% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	13.1%	11.8%	10.6%	8.4%	8.5%	29.1%	22.8%	19.8%	19%	13.5%	-
Value Creation Index ⓘ	-0.1	-0.2	-0.3	-0.4	-0.4	1.1	0.6	0.4	0.4	0.0	-
Growth Parameters ⓘ
Sales ⓘ	145	165	172	157	194	311	256	315	245	268	383
Sales YoY Gr.	-	13.7%	4.3%	-8.7%	23.8%	60.3%	-17.8%	23.1%	-22.1%	9.1%	-
Adj EPS ⓘ	0	0	0	0	0.1	0.3	0.3	0.3	0.3	0.2	0.2
YoY Gr.	-	33.3%	0%	0%	25%	460%	-3.6%	7.4%	3.5%	-26.7%	-
BVPS (₹) ⓘ	0.1	0.2	0.4	0.5	0.5	0.8	1.1	1.3	1.6	1.9	2
Adj Net Profit ⓘ	0.8	1	1.4	1.6	1.8	10.4	10.2	10.9	11.2	8.4	7
Cash Flow from Ops. ⓘ	-4.2	-3.6	-12	6.4	-4.5	5.5	-10.1	-5.9	32.4	-16.1	-
Debt/CF from Ops. ⓘ	-6.2	-8.6	-2.7	4.1	-6.8	4.5	-3.6	-7.6	0.6	-2.3	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	7.1%	6.6%	1.5%	9.1%
Adj EPS ⓘ	24.8%	34.5%	-6.6%	-26.7%
BVPSⓘ	34.3%	29.9%	20.4%	13.5%
Share Price	-	-43.1%	-80.7%	-33.4%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	28.5	26.9	14.2	10	9.9	43	29.5	24.3	20.2	12.9	9.3
Op. Profit Mgn % ⓘ	3	3.1	3.2	3.2	2.5	5.1	6.1	5.4	6.8	4.7	3
Net Profit Mgn % ⓘ	0.6	0.6	0.8	1.1	0.9	3.3	4	3.5	4.6	3.1	1.8
Debt to Equity ⓘ	8	7.7	2.1	1.5	1.6	0.9	0.9	0.9	0.3	0.5	0
Working Cap Days ⓘ	76	78	95	108	90	69	105	107	142	144	65
Cash Conv. Cycle ⓘ	47	59	76	93	78	55	89	91	114	109	54

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	145	165	172	157	194	311	256	315	245	268
Operating Expenses ⓘ +	141	160	166	152	189	295	240	298	229	255
Manufacturing Costs	8	10	6	6	7	7	10	9	8	11
Material Costs	130	146	158	144	180	286	227	285	216	240
Employee Cost	1	1	2	2	1	1	2	1	2	2
Other Costs ⓘ	1	1	1	1	1	1	1	2	3	2
Operating Profit ⓘ	4	5	6	5	5	16	16	17	17	12
Operating Profit Margin (%)	2.9%	3.0%	3.2%	3.2%	2.5%	5.1%	6.1%	5.4%	6.8%	4.7%
Other Income ⓘ +	0	0	0	0	0	0	0	1	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	2	2	2	2	2	1	1	2	1	1
Depreciation ⓘ	1	1	1	1	1	1	1	1	1	0
Profit Before Tax ⓘ	1	2	2	2	2	14	14	15	15	11
Tax ⓘ	0	1	1	1	1	4	4	4	4	3
Profit After Tax	1	1	1	2	2	10	10	11	11	8
PAT Margin (%)	0.5%	0.6%	0.8%	1.1%	0.9%	3.3%	4.0%	3.5%	4.6%	3.1%
Adjusted EPS (₹)	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.3	0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of MK Proteins - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	3	4	15	17	19	29	40	50	61	69
Share Capital ⓘ	1	3	4	4	4	4	4	13	38	38
Reserves ⓘ	3	2	11	13	15	25	35	37	24	32
Debt +	26	30	32	26	30	25	37	44	19	37
Long Term Debt	8	12	12	2	4	4	3	3	0	1
Short Term Debt	18	18	21	24	26	20	34	42	19	37
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	8	9	5	2	4	8	5	5	11	19
Others Liabilities ⓘ	2	3	3	2	3	5	5	6	6	6
Total Liabilities ⓘ	39	47	56	47	56	67	86	105	98	132
Fixed Assets
Net Fixed Assets ⓘ +	7	7	6	4	3	2	3	3	3	4
Gross Block	9	10	10	4	3	10	11	12	12	14
Accumulated Depreciation	2	3	5	0	0	7	8	9	10	10
CWIP ⓘ	0	0	0	0	0	0	0	0	6	7
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	20	33	30	29	39	38	50	71	79	111
Trade Receivables	11	5	19	11	10	21	29	16	4	1
Cash Equivalents	0	0	0	0	0	0	0	0	0	0
Others Assets ⓘ	1	2	2	3	5	6	4	15	6	9
Total Assets ⓘ	39	47	56	47	56	67	86	105	98	132

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-4	-4	-12	6	-4	6	-10	-6	32	-16
PBT ⓘ	1	2	2	2	2	14	14	15	15	11
Adjustment ⓘ	3	3	3	3	3	2	2	2	1	1
Changes in Working Capital ⓘ	-6	-6	-15	4	-7	-8	-21	-18	19	-24
Tax Paid ⓘ	-0	-0	-1	-1	-1	-1	-4	-5	-4	-4
Cash Flow From Investing Activity ⓘ +	-2	-1	-0	0	0	-0	-2	0	-6	-1
Capex	-2	-1	0	0	0	-0	-2	5	0	0
Net Investments	0	0	0	0	0	0	0	-5	0	0
Others ⓘ	-0	-0	-0	0	0	0	-0	0	-6	-2
Cash Flow From Financing Activity ⓘ +	6	5	12	-7	4	-5	12	6	-27	18
Net Proceeds from Shares ⓘ	0	0	10	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	1	4	2	-13	2	1	-2	-0	-3	-0
Interest Paid ⓘ	0	0	0	0	0	0	0	-2	-1	-1
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	6	0	1	6	2	-6	14	8	-23	19
Net Cash Flow ⓘ	0	-0	0	-0	0	-0	0	0	0	-0

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	24.9	27.1	14.62	10.07	10.07	43.03	29.54	24.44	20.21	12.87
ROCE (%)	13.06	11.82	10.57	8.42	8.54	29.13	22.82	19.78	18.99	13.46
Asset Turnover Ratio	3.9	3.85	3.35	3.04	3.75	5.04	3.35	3.3	2.42	2.33
PAT to CFO Conversion(x)	-4	-4	-12	3	-2	0.6	-1	-0.55	2.91	-2
Working Capital Days
Receivable Days	20.30	16.90	24.50	34.20	19.10	17.70	35.60	26.20	14.60	3.40
Inventory Days	52.80	59.10	67.30	69.10	64.30	45	62.40	70	111.70	129.70
Payable Days	27.80	21.30	16.90	9.80	6.30	7.50	10.50	6.30	13.70	23.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

MK Proteins Ltd FAQs

The current trading price of MK Proteins on 12-Jun-2026 16:59 is ₹4.72.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 11-Jun-2026 the market cap of MK Proteins stood at ₹177.2 Cr

The latest P/E ratio of MK Proteins as of 11-Jun-2026 is 25.94.

The latest P/B ratio of MK Proteins as of 11-Jun-2026 is 2.32.

The 52-week high of MK Proteins is ₹9.75 and the 52-week low is ₹3.80.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of MK Proteins is ₹383 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that MK Proteins Ltd is a below average quality company.

The key valuation ratios of MK Proteins Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of MK Proteins Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About MK Proteins Ltd

MK Proteins was incorporated as MK Proteins Private Limited under the provisions of the Companies Act, 1956 vide certificate of incorporation dated June 15, 2012. Subsequently, the company was converted into public limited company and the name of the company was changed to ‘MK Proteins Limited’ pursuant to shareholder’s resolution dated January 20, 2017 and vide fresh certificate of incorporation dated February 08, 2017.

The company is focussed at production of highest quality of edible oil. Its refinery is completely mechanized and it produces rice bran oil, sunflower oil etc with protein content, with controlled fibre free from oil residue, ash and sand & silica. This is possible only through sustained levels of cleaning, storage and monitoring arrangements. The company based on its extensive experience of its promoters and its standards, conforms to major specifications and customer requirements.

Its manufacturing process involves refining of Crude Oils to obtain Refined Rice Bran Oil, Canola Oil, Soya Bean Oil, Sunflower Oil and Rice Bran Bleached Oil. During the refining process certain by-products are also manufactured such as Rice Bran Fatty Acid Oil, Rice Bran Wax, Gums and Spent Earth which are also saleable. Further, it also imports crude oils, process them and sell the finished product. It also trades in both edible and non-edible oils.

Business area of the company

The company is engaged in the manufacturing of Vegetable Refined Oil and its by-products (i.e. Rice Bran Fatty, Wax, Gums and Spent Earth etc.). Further, it also imports crude oils, process them and sell the finished product. It also trades in both edible and non-edible oils.

Products of the company

Rice bran fatty acid oil
Rice bran wax
Gums
Spent earth

MK Proteins Ltd (MKPL)

MK Proteins Ltd (MKPL)

MK Proteins stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of MK Proteins - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

MK Proteins Ltd FAQs

About MK Proteins Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

MK Proteins Ltd (MKPL)

MK Proteins Ltd (MKPL)

MK Proteins stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of MK Proteins - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

MK Proteins Ltd FAQs

What is the share price of MK Proteins?

What is the market cap of MK Proteins?

What is the P/E ratio of MK Proteins?

What is the P/B ratio of MK Proteins?

What is the 52-week high and low of MK Proteins?

What is the TTM revenue of MK Proteins?

Is MK Proteins Ltd a good quality company?

Is MK Proteins Ltd undervalued or overvalued?

Is MK Proteins Ltd a good buy now?

About MK Proteins Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.